| Title |
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
|
|---|---|
| Published in |
Journal of Clinical Oncology, October 2022
|
| DOI | 10.1200/jco.22.00644 |
| Pubmed ID | |
| Authors |
Matthew P. Deek, Kim Van der Eecken, Philip Sutera, Rebecca A. Deek, Valérie Fonteyne, Adrianna A. Mendes, Karel Decaestecker, Ana Ponce Kiess, Nicolaas Lumen, Ryan Phillips, Aurélie De Bruycker, Mark Mishra, Zaker Rana, Jason Molitoris, Bieke Lambert, Louke Delrue, Hailun Wang, Kathryn Lowe, Sofie Verbeke, Jo Van Dorpe, Renée Bultijnck, Geert Villeirs, Kathia De Man, Filip Ameye, Daniel Y. Song, Theodore DeWeese, Channing J. Paller, Felix Y. Feng, Alexander Wyatt, Kenneth J. Pienta, Maximillian Diehn, Soren M. Bentzen, Steven Joniau, Friedl Vanhaverbeke, Gert De Meerleer, Emmanuel S. Antonarakis, Tamara L. Lotan, Alejandro Berlin, Shankar Siva, Piet Ost, Phuoc T. Tran |
Twitter Demographics
The data shown below were collected from the profiles of 203 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 45 | 22% |
| France | 14 | 7% |
| Spain | 9 | 4% |
| Germany | 9 | 4% |
| Belgium | 8 | 4% |
| Italy | 7 | 3% |
| Australia | 6 | 3% |
| Switzerland | 5 | 2% |
| Turkey | 4 | 2% |
| Other | 28 | 14% |
| Unknown | 68 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 121 | 60% |
| Scientists | 45 | 22% |
| Practitioners (doctors, other healthcare professionals) | 32 | 16% |
| Science communicators (journalists, bloggers, editors) | 5 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 56 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 29% |
| Other | 4 | 7% |
| Student > Postgraduate | 4 | 7% |
| Professor > Associate Professor | 3 | 5% |
| Student > Master | 3 | 5% |
| Other | 9 | 16% |
| Unknown | 17 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 29 | 52% |
| Biochemistry, Genetics and Molecular Biology | 3 | 5% |
| Unspecified | 2 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
| Engineering | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 20 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 171. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 June 2023.
All research outputs
#223,546
of 24,495,755 outputs
Outputs from Journal of Clinical Oncology
#395
of 21,492 outputs
Outputs of similar age
#6,277
of 430,938 outputs
Outputs of similar age from Journal of Clinical Oncology
#12
of 212 outputs
Altmetric has tracked 24,495,755 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 21,492 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,938 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 212 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.